- Pharma giant Roche is acquiring Flatiron Health for $1.9 billion.
- The
- Flatiron collects clinical data from cancer patients — such as what medications patients have taken and how they have responded to them.
ADVERTISEMENT
Pharma giant Roche is buying cancer tech startup Flatiron Health for $1.9 billion (ROG)
The New York-based cancer technology startup had previously been valued at $1.2 billion after raising $175 million from investors including Roche.
Roche is buying Flatiron Health.
JOIN OUR PULSE COMMUNITY!
ADVERTISEMENT
Eyewitness? Submit your stories now via social or:
Email: eyewitness@pulse.ng
ADVERTISEMENT